Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVRAAS: Topical Statins for Active Vitiligo
NCT03247400Phase 2Completed
- Sponsor
- Nicolaus Copernicus University
- Start
- Dec 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of simvastatin gel (Ain Shams University) and atorvastatin 1.2% gel in Vitiligo (2 arms), sponsored by Nicolaus Copernicus University. Primary endpoint: Repigmentation of vitiligous lesions at 12 weeks. Started Dec 2016; status: completed.
02
Drugs
simvastatin gel (Ain Shams University)atorvastatin 1.2% gel
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT03247400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03247400.